Therapeutic Potential of Small Interfering RNA for Brain Diseases

作者: Amy E. Lovett-Racke

DOI: 10.1007/978-3-642-00475-9_13

关键词:

摘要: RNA interference (RNAi) is an evolutionarily conserved mechanism found in all eukaryotes to degrade messenger (mRNA) that has sequence homology short double-stranded (dsRNA). It believed the usual biological function of RNAi safeguard host cells from viruses and transposons, which can endanger genome. Expression dsRNA cell signals a cascade intracellular events generate small interfering (siRNA) segments mediate degradation complementary mRNA subsequent failure express protein. Recently, engineered siRNA been used study normal significance vast number genes variety types, as well role specific disease pathogenesis. Thus, therapeutic potential specifically suppress expression proteins associated with processes. The exquisite specificity siRNA-mediated gene suppression provides opportunity target single point mutations hereditary disorders, unique pathogenic tumor malignancies, are critical for mediating pathology many diseases. fact functions at transcription level means virtually any be targeted suppression, providing strategy develop therapeutics neurological diseases, have no effective therapies.

参考文章(97)
Rudolph L Juliano, Peptide-oligonucleotide conjugates for the delivery of antisense and siRNA Current Opinion in Molecular Therapeutics. ,vol. 7, pp. 132- 136 ,(2005)
J. Elm n, Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality Nucleic Acids Research. ,vol. 33, pp. 439- 447 ,(2005) , 10.1093/NAR/GKI193
Rabinder Prinjha, Stephen E. Moore, Mary Vinson, Sian Blake, Rachel Morrow, Gary Christie, David Michalovich, David L. Simmons, Frank S. Walsh, Inhibitor of neurite outgrowth in humans. Nature. ,vol. 403, pp. 383- 384 ,(2000) , 10.1038/35000287
Yi Luo, Brad Bolon, Steve Kahn, Brian D. Bennett, Safura Babu-Khan, Paul Denis, Wei Fan, Hue Kha, Jianhua Zhang, Yunhua Gong, Laura Martin, Jean-Claude Louis, Qiao Yan, William G. Richards, Martin Citron, Robert Vassar, Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation. Nature Neuroscience. ,vol. 4, pp. 231- 232 ,(2001) , 10.1038/85059
P. S. Albert, D. E. Mcfarlin, D. Burnett, Seong-Hee Pak, M. K. Racke, B. Cannella, D. E. Scott, C. S. Raine, Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. Journal of Immunology. ,vol. 154, pp. 450- 458 ,(1995)
Andrew Fire, SiQun Xu, Mary K. Montgomery, Steven A. Kostas, Samuel E. Driver, Craig C. Mello, Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans Nature. ,vol. 391, pp. 806- 811 ,(1998) , 10.1038/35888
Anne R. Gocke, Petra D. Cravens, Li-Hong Ben, Rehana Z. Hussain, Sara C. Northrop, Michael K. Racke, Amy E. Lovett-Racke, T-bet Regulates the Fate of Th1 and Th17 Lymphocytes in Autoimmunity Journal of Immunology. ,vol. 178, pp. 1341- 1348 ,(2007) , 10.4049/JIMMUNOL.178.3.1341
W Ridgway, L Steinman, S Brocke, C Dinisco, D Dalton, I A Ferber, C G Fathman, C Taylor-Edwards, Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). Journal of Immunology. ,vol. 156, pp. 5- 7 ,(1996)
Ian A. Ramshaw, William B. Cowden, Sue Fordham, C. C A Bernard, David O. Willenborg, IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Journal of Immunology. ,vol. 157, pp. 3223- 3227 ,(1996)